logo
Select company
Select metric
$ 0Net Cash Flow - Investing
VS
Market
75
Sector
59
Industry
46
History
-
$ 1.21Close
$ 0.45 - $ 2.21 52-Week Range
Ticker Information

Ticker

KAPA

Company Name

KAIROS PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

KAIROS PHARMA LTD - Net Cash Flow - Investing Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KAPA - CF - Investing Historical data
DateNet Cash Flow - Investing
6/30/2025$ 0
3/31/2025$ 0
12/31/2024$ 0
9/30/2024$ 0
12/31/2023$ 0
12/31/2022$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KAIROS PHARMA LTD's latest trailing twelve months (TTM) CF - Investing stands at $ 0.
  • Over the past 5 years, KAIROS PHARMA LTD's average CF - Investing has been $ 0.
  • The median CF - Investing for KAIROS PHARMA LTD during this period was $ 0
  • KAIROS PHARMA LTD reached its highest CF - Investing over the past 5 years at $ 0.
  • The lowest CF - Investing recorded by KAIROS PHARMA LTD in the same timeframe $ 0

Definition of Net Cash Flow - Investing

[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].

KAPA - Net Cash Flow - Investing, Last 5 years

$ 0

Minimum

Dec 31, 2022

$ 0

Maximum

Dec 31, 2022

$ 0

Average

$ 0

Median

CF - Investing Benchmark Analysis

The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.34M with a standard deviation of $ 83.4M.
The following table provides additional summary stats:
CF - Investing in the Market:
filtered constituents3.16K
min$ -292.23M
max$ 241M
average$ -35.34M
median$ -6.39M
std$ 83.4M